Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland
Abstract
Authors
JT Joensuu KJ Aaltonen P Aronen T Sokka K Puolakka R Tuompo M Korpela M Vasala K Ilva D Nordström M Blom